Big pharma is too greedy for innovation to create widespread solutions

While Big Pharma is ripping off Americans, and breaking health systems across Europe, it’s also failing to provide the medicines people across the world most need. The search for goldmine drugs means research into diseases suffered by less wealthy people, in less wealthy countries, takes a back seat. So does research into potentially catastrophic epidemics or new-generation antibiotics. Even though antibiotic resistance is likely to lead to tens of millions of deaths a year in coming decades, it’s simply not profitable enough for corporations used to making eye-watering returns.